Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib

Sorafenib remains the standard care for patients with hepatocellular carcinoma (HCC) even though it has low antitumor efficacy. Protein neddylation is abnormally activated in many types of human cancer. However, whether dysregulation of neddylation is involved in HCC progression and whether targetin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Rep
Main Authors: Yang, Zelong, Zhang, Jie, Lin, Xiaotong, Wu, Di, Li, Guixi, Zhong, Chunlian, Fang, Lei, Jiang, Peng, Yin, Liangyu, Zhang, Leida, Bie, Ping, Xie, Chuan-Ming
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2019
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489087/
https://ncbi.nlm.nih.gov/pubmed/31002342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7098
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki